about
The role of bile acids in metabolic regulationStrategy for NMR metabolomic analysis of urine in mouse models of obesity--from sample collection to interpretation of acquired data.LEADER-4: blood pressure control in patients with type 2 diabetes and high cardiovascular risk: baseline data from the LEADER randomized trial.Association of macrophage inhibitory cytokine-1 with nutritional status, body composition and bone mineral density in patients with anorexia nervosa: the influence of partial realimentation.Use of non-invasive parameters of non-alcoholic steatohepatitis and liver fibrosis in daily practice--an exploratory case-control studyAlterations in regulation of energy homeostasis in cyclic nucleotide phosphodiesterase 3B-null miceComparison of three protocols for tight glycemic control in cardiac surgery patients.Hyperbilirubinemia Protects against Aging-Associated Inflammation and Metabolic Deterioration.The role of LMNA in adipose: a novel mouse model of lipodystrophy based on the Dunnigan-type familial partial lipodystrophy mutation.Twice-daily insulin degludec/insulin aspart provides superior fasting plasma glucose control and a reduced rate of hypoglycaemia compared with biphasic insulin aspart 30 in insulin-naïve adults with Type 2 diabetes.Laparoscopic sleeve gastrectomy without over-sewing of the staple line is effective and safe.Renal Effects of DPP-4 Inhibitors: A Focus on MicroalbuminuriaGlucose control in the ICU: is there a time for more ambitious targets again?The role of adipose tissue immune cells in obesity and low-grade inflammation.Serum preadipocyte factor-1 concentrations in females with obesity and type 2 diabetes mellitus: the influence of very low calorie diet, acute hyperinsulinemia, and fenofibrate treatment.Serum concentrations and tissue expression of components of insulin-like growth factor-axis in females with type 2 diabetes mellitus and obesity: the influence of very-low-calorie diet.The effect of very-low-calorie diet on mRNA expression of inflammation-related genes in subcutaneous adipose tissue and peripheral monocytes of obese patients with type 2 diabetes mellitus.Enhanced expressions of mRNA for neuropeptide Y and interleukin 1 beta in hypothalamic arcuate nuclei during adjuvant arthritis-induced anorexia in Lewis rats.Lymphocytes and macrophages in adipose tissue in obesity: markers or makers of subclinical inflammation?Angiopoietin-like protein 6 in patients with obesity, type 2 diabetes mellitus, and anorexia nervosa: The influence of very low-calorie diet, bariatric surgery, and partial realimentation.Palmitoylated PrRP analog decreases body weight in DIO rats but not in ZDF rats.Blood glucose control by a model predictive control algorithm with variable sampling rate versus a routine glucose management protocol in cardiac surgery patients: a randomized controlled trial.Metabolomic profiling of urinary changes in mice with monosodium glutamate-induced obesity.Perioperative Tight Glucose Control Reduces Postoperative Adverse Events in Nondiabetic Cardiac Surgery Patients.Mutated Huntingtin Causes Testicular Pathology in Transgenic Minipig Boars.Novel lipidized analogs of prolactin-releasing peptide have prolonged half-lives and exert anti-obesity effects after peripheral administration.The use of continuous glucose monitoring combined with computer-based eMPC algorithm for tight glucose control in cardiosurgical ICU.Changes in energy metabolism in pheochromocytoma.Evaluating glycemic control algorithms by computer simulations.Clinical evaluation of subcutaneous lactate measurement in patients after major cardiac surgery.Increased proinflammatory cytokine production in adipose tissue of obese patients with chronic kidney disease.Mechanism of impaired glucose metabolism during nilotinib therapy in patients with chronic myelogenous leukemia.Estradiol supplementation helps overcome central leptin resistance of ovariectomized mice on a high fat diet.Serum concentrations and tissue expression of a novel endocrine regulator fibroblast growth factor-21 in patients with type 2 diabetes and obesity.The influence of short-term fasting on serum leptin levels, and selected hormonal and metabolic parameters in morbidly obese and lean females.Serum leptin levels in patients with primary hyperaldosteronism before and after treatment: relationships to insulin sensitivity.WY14,643, a peroxisome proliferator-activated receptor alpha (PPARalpha ) agonist, improves hepatic and muscle steatosis and reverses insulin resistance in lipoatrophic A-ZIP/F-1 mice.Adrenalectomy improves diabetes in A-ZIP/F-1 lipoatrophic mice by increasing both liver and muscle insulin sensitivity.Cutaneous trematode Collyriclum faba in wild birds in the central European Carpathians.Soluble leptin receptor levels in patients with anorexia nervosa.
P50
Q26770807-7A24A293-3400-46E5-9804-7547FE8B1191Q30986675-6BE84E3F-FCF0-4D05-B0FE-33B75BB74837Q31043538-7AEA39B9-3ABD-4C6F-81F5-A70224350FA5Q33872067-050213E0-9EBA-4C42-85F6-E5ECC919575CQ34414807-AD90C089-F6FD-4B95-ADE4-E1F73E6919F0Q35189557-EEC15839-2650-4AE8-B3EA-C5BACEC363C6Q37163690-DB1A6A11-F939-417C-B00A-DA2E228A3290Q37172167-0E23B2E0-86E7-465B-823D-CE37E3FD5686Q37190360-BB55E801-4156-4B7C-9DC5-CFDD5411193BQ37337300-845D50C5-A6AC-4357-8B35-4E620A64B63CQ37697742-5F1B16FC-D726-4257-AA5A-EA7E32E39D0FQ38148750-3CE00412-82D0-48B5-B1F8-9FDF1BC6A9F7Q38215994-677FD47A-CAC6-42AE-8188-72A2A4BE1C8CQ38227543-73355343-5EE3-4E9D-93A4-390EF315F8B6Q38313082-FCA011E9-D93E-4B8A-87AD-C74418E809D0Q38325713-099C2B4D-21A5-446A-98A7-10DE45EC804AQ38337571-955AEC61-A51F-493F-8556-ED037E787D73Q38352196-9307FB9F-DE2C-4208-8D39-11817AB33D73Q38985223-87FF620F-FAF3-4210-B2FA-5B93B33B2022Q39803912-814AAD14-2572-461A-8281-2F8D84995A61Q39975556-C90E9494-D884-46FE-B929-A66A6BF00655Q40206243-A2E7BAF3-3744-4F74-933C-94316CBD8E5CQ40312485-987F8BA6-8DDC-4603-B334-8C2819EE3564Q40830654-61A331C8-933A-4A13-9008-CA9EB5656CB7Q40863618-C116C816-007F-4BBC-9984-64EDD41EA141Q41221501-68F32B50-4880-4799-B2CD-D75DE8AF9044Q41241440-6524A2EE-7DD7-478F-8881-D5A2B1E814CEQ42521092-213B8A5E-5B63-4E12-9F39-B2F97CD8537BQ42597288-350BF105-F17D-4CED-812D-9F6A5D39D560Q42643274-6B6B9E65-C5B2-4BC4-8A9E-5BCD4CC69259Q42958370-89B844E3-8973-4399-BE0C-2777DD76A30AQ42958726-5B5FA8EA-3AD4-4537-85DB-2271C1C28FCEQ43202413-D7546461-A694-44D3-93EF-4B575B194A72Q43287114-4E6D94D3-35B5-4FB3-A59D-D8301EB28355Q43655171-9C89CACD-976A-4888-AA1D-C309F7715753Q43882708-C757A2EA-C706-472B-8C52-076A4B764302Q43982367-26550517-5EEF-4EE6-8470-F3551FBE451EQ44043206-D2494C25-F8F9-447A-8213-A5A2E76EECCBQ44197157-A8F8F0D0-CC50-42D2-93D1-90F6DF52B804Q44254213-A0CE87BA-A895-4B17-BF94-994188BCDCDA
P50
description
hulumtues
@sq
researcher
@en
ricercatore
@it
wetenschapper
@nl
հետազոտող
@hy
name
Martin Haluzík
@ast
Martin Haluzík
@br
Martin Haluzík
@co
Martin Haluzík
@cs
Martin Haluzík
@da
Martin Haluzík
@de
Martin Haluzík
@en
Martin Haluzík
@es
Martin Haluzík
@fr
Martin Haluzík
@id
type
label
Martin Haluzík
@ast
Martin Haluzík
@br
Martin Haluzík
@co
Martin Haluzík
@cs
Martin Haluzík
@da
Martin Haluzík
@de
Martin Haluzík
@en
Martin Haluzík
@es
Martin Haluzík
@fr
Martin Haluzík
@id
altLabel
Martin Haluzik
@en
prefLabel
Martin Haluzík
@ast
Martin Haluzík
@br
Martin Haluzík
@co
Martin Haluzík
@cs
Martin Haluzík
@da
Martin Haluzík
@de
Martin Haluzík
@en
Martin Haluzík
@es
Martin Haluzík
@fr
Martin Haluzík
@id
P214
P1053
I-8190-2017
P106
P1153
8449226600
P1343
P21
P214
P31
P3829
P496
0000-0002-0201-6888
P569
1970-03-25T00:00:00Z
P691
P735
P7859
viaf-85311214